In this supplement, Paul P. Dobesh, PharmD, examines NVAF in the obese and morbidly obese patient population with a focus on anticoagulant treatment options. Topics include:
- Understanding the obesity risk in patients with NVAF
- Challenges of anticoagulation with warfarin in patients with obesity
- NVAF patients with obesity
Click here to access the supplement.
January 2020 cp-127604v1